These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34035807)

  • 1. Galectin-3 Inhibitors Suppress Anoikis Resistance and Invasive Capacity in Thyroid Cancer Cells.
    Lee JJ; Hsu YC; Li YS; Cheng SP
    Int J Endocrinol; 2021; 2021():5583491. PubMed ID: 34035807
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Bratteby K; Torkelsson E; L'Estrade ET; Peterson K; Shalgunov V; Xiong M; Leffler H; Zetterberg FR; Olsson TG; Gillings N; Nilsson UJ; Herth MM; Erlandsson M
    J Med Chem; 2020 Jan; 63(2):747-755. PubMed ID: 31846326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells.
    Kim HR; Lin HM; Biliran H; Raz A
    Cancer Res; 1999 Aug; 59(16):4148-54. PubMed ID: 10463621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baicalein induced apoptosis and autophagy of undifferentiated thyroid cancer cells by the ERK/PI3K/Akt pathway.
    Wang M; Qiu S; Qin J
    Am J Transl Res; 2019; 11(6):3341-3352. PubMed ID: 31312348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest.
    Yoshii T; Fukumori T; Honjo Y; Inohara H; Kim HR; Raz A
    J Biol Chem; 2002 Mar; 277(9):6852-7. PubMed ID: 11724777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Intrinsic Galectin-3 Attenuates Neutrophil ROS-Dependent Killing of
    Wu SY; Huang JH; Chen WY; Chan YC; Lin CH; Chen YC; Liu FT; Wu-Hsieh BA
    Front Immunol; 2017; 8():48. PubMed ID: 28217127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 deficiency protects pancreatic islet cells from cytokine-triggered apoptosis in vitro.
    Saksida T; Nikolic I; Vujicic M; Nilsson UJ; Leffler H; Lukic ML; Stojanovic I; Stosic-Grujicic S
    J Cell Physiol; 2013 Jul; 228(7):1568-76. PubMed ID: 23280610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion.
    Zheng H; Li Y; Wang Y; Zhao H; Zhang J; Chai H; Tang T; Yue J; Guo AM; Yang J
    Toxicol Appl Pharmacol; 2014 Oct; 280(1):10-20. PubMed ID: 25094029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of gap junction transfer sensitizes thyroid cancer cells to anoikis.
    Jensen K; Patel A; Klubo-Gwiezdzinska J; Bauer A; Vasko V
    Endocr Relat Cancer; 2011 Oct; 18(5):613-26. PubMed ID: 21813730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of galectin-1 by TLR-dependent PI3K activation enhances epithelial-mesenchymal transition of metastatic ovarian cancer cells.
    Park GB; Chung YH; Kim D
    Oncol Rep; 2017 May; 37(5):3137-3145. PubMed ID: 28350104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.
    Luey BC; May FE
    Mol Cancer; 2016 Jan; 15():8. PubMed ID: 26801096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of galectin-3 represses osteosarcoma cell migration and invasion through inhibition of FAK/Src/Lyn activation and β-catenin expression and increases susceptibility to chemotherapeutic agents.
    Park GB; Kim DJ; Kim YS; Lee HK; Kim CW; Hur DY
    Int J Oncol; 2015 Jan; 46(1):185-94. PubMed ID: 25339127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells.
    Schempp CM; von Schwarzenberg K; Schreiner L; Kubisch R; Müller R; Wagner E; Vollmar AM
    Mol Cancer Ther; 2014 Apr; 13(4):926-37. PubMed ID: 24482380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor p16INK4a--modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells.
    André S; Sanchez-Ruderisch H; Nakagawa H; Buchholz M; Kopitz J; Forberich P; Kemmner W; Böck C; Deguchi K; Detjen KM; Wiedenmann B; von Knebel Doeberitz M; Gress TM; Nishimura S; Rosewicz S; Gabius HJ
    FEBS J; 2007 Jul; 274(13):3233-56. PubMed ID: 17535296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives.
    Bartolazzi A; Sciacchitano S; D'Alessandria C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas.
    Rossi ED; Straccia P; Palumbo M; Stigliano E; Revelli L; Lombardi CP; Santeusanio G; Pontecorvi A; Fadda G
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):237-41. PubMed ID: 23235344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of nuclear, cytoplasmic expression of galectin-3 with beta-catenin/Wnt-pathway activation in thyroid carcinoma.
    Weinberger PM; Adam BL; Gourin CG; Moretz WH; Bollag RJ; Wang BY; Liu Z; Lee JR; Terris DJ
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):503-10. PubMed ID: 17515507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPW-RX40 restores anoikis sensitivity of human breast cancer cells by inhibiting integrin/FAK signaling.
    Chen IH; Shih HC; Hsieh PW; Chang FR; Wu YC; Wu CC
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):330-40. PubMed ID: 26386190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFL7 as a novel therapeutic candidate regulates cell invasion and anoikis in colorectal cancer through PI3K/AKT signaling pathway.
    Juan Z; Dake C; Tanaka K; Shuixiang H
    Int J Clin Oncol; 2021 Jun; 26(6):1099-1108. PubMed ID: 33635474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor p16 INK4a: Downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model.
    Sanchez-Ruderisch H; Fischer C; Detjen KM; Welzel M; Wimmel A; Manning JC; André S; Gabius HJ
    FEBS J; 2010 Sep; 277(17):3552-63. PubMed ID: 20695889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.